Cargando…
A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors
Cyclooxygenase-2 inhibitors (coxibs) are characterized by multiple molecular off-target effects and increased coronary artery disease (CAD) risk. Here, we systematically explored common variants of genes representing molecular targets of coxibs for association with CAD. Given a broad spectrum of ple...
Autores principales: | Brænne, Ingrid, Willenborg, Christina, Tragante, Vinicius, Kessler, Thorsten, Zeng, Lingyao, Reiz, Benedikt, Kleinecke, Mariana, von Ameln, Simon, Willer, Cristen J., Laakso, Markku, Wild, Philipp S., Zeller, Tanja, Wallentin, Lars, Franks, Paul W., Salomaa, Veikko, Dehghan, Abbas, Meitinger, Thomas, Samani, Nilesh J., Asselbergs, Folkert W., Erdmann, Jeanette, Schunkert, Heribert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579257/ https://www.ncbi.nlm.nih.gov/pubmed/28860667 http://dx.doi.org/10.1038/s41598-017-10928-4 |
Ejemplares similares
-
Genomic correlates of glatiramer acetate adverse cardiovascular effects lead to a novel locus mediating coronary risk
por: Brænne, Ingrid, et al.
Publicado: (2017) -
Whole-exome sequencing in an extended family with myocardial infarction unmasks familial hypercholesterolemia
por: Brænne, Ingrid, et al.
Publicado: (2014) -
Network analysis of coronary artery disease risk genes elucidates disease mechanisms and druggable targets
por: Lempiäinen, Harri, et al.
Publicado: (2018) -
A familial congenital heart disease with a possible multigenic origin involving a mutation in BMPR1A
por: Demal, Till Joscha, et al.
Publicado: (2019) -
Investigating the impact of a mutation in PDE5A on myocardial infarction
por: Dang, Tan A, et al.
Publicado: (2015)